id sid tid token lemma pos dpc-1922 1 1 dermatology dermatology NOUN dpc-1922 1 2 : : PUNCT dpc-1922 1 3 practical practical ADJ dpc-1922 1 4 and and CCONJ dpc-1922 1 5 conceptual conceptual ADJ dpc-1922 1 6 research research NOUN dpc-1922 1 7 letter letter NOUN dpc-1922 2 1 | | ADV dpc-1922 2 2 dermatol dermatol ADJ dpc-1922 2 3 pract pract NOUN dpc-1922 2 4 concept concept NOUN dpc-1922 2 5 . . PUNCT dpc-1922 3 1 2022;12(3):e2022105 2022;12(3):e2022105 NUM dpc-1922 3 2 1 1 NUM dpc-1922 3 3 do do AUX dpc-1922 3 4 pd-1 pd-1 ADJ dpc-1922 3 5 / / SYM dpc-1922 3 6 pdl-1 pdl-1 ADJ dpc-1922 3 7 inhibitors inhibitor NOUN dpc-1922 3 8 play play VERB dpc-1922 3 9 a a DET dpc-1922 3 10 triggering trigger VERB dpc-1922 3 11 or or CCONJ dpc-1922 3 12 causative causative ADJ dpc-1922 3 13 role role NOUN dpc-1922 3 14 in in ADP dpc-1922 3 15 the the DET dpc-1922 3 16 development development NOUN dpc-1922 3 17 of of ADP dpc-1922 3 18 paraneoplastic paraneoplastic ADJ dpc-1922 3 19 dermatomyositis dermatomyositis NOUN dpc-1922 3 20 ? ? PUNCT dpc-1922 4 1 michela michela PROPN dpc-1922 4 2 starace1 starace1 PROPN dpc-1922 4 3 , , PUNCT dpc-1922 4 4 francesca francesca PROPN dpc-1922 4 5 pampaloni2 pampaloni2 PROPN dpc-1922 4 6 , , PUNCT dpc-1922 4 7 miriam miriam PROPN dpc-1922 4 8 anna anna PROPN dpc-1922 4 9 carpanese1 carpanese1 PROPN dpc-1922 4 10 , , PUNCT dpc-1922 4 11 andrea andrea PROPN dpc-1922 4 12 sechi1 sechi1 PROPN dpc-1922 4 13 , , PUNCT dpc-1922 4 14 francesca francesca PROPN dpc-1922 4 15 bruni1 bruni1 PROPN dpc-1922 4 16 , , PUNCT dpc-1922 4 17 aurora aurora PROPN dpc-1922 4 18 alessandrini1 alessandrini1 PROPN dpc-1922 4 19 1 1 NUM dpc-1922 4 20 dermatology dermatology NOUN dpc-1922 4 21 -irccs -irccs NOUN dpc-1922 4 22 policlinico policlinico PROPN dpc-1922 4 23 di di PROPN dpc-1922 4 24 sant’orsola sant’orsola PROPN dpc-1922 4 25 department department PROPN dpc-1922 4 26 of of ADP dpc-1922 4 27 experimental experimental ADJ dpc-1922 4 28 , , PUNCT dpc-1922 4 29 diagnostic diagnostic ADJ dpc-1922 4 30 and and CCONJ dpc-1922 4 31 specialty specialty NOUN dpc-1922 4 32 medicine medicine NOUN dpc-1922 4 33 ( ( PUNCT dpc-1922 4 34 dimes dime NOUN dpc-1922 4 35 ) ) PUNCT dpc-1922 4 36 alma alma NOUN dpc-1922 4 37 mater mater NOUN dpc-1922 4 38 studiorum studiorum PROPN dpc-1922 4 39 university university PROPN dpc-1922 4 40 of of ADP dpc-1922 4 41 bologna bologna PROPN dpc-1922 4 42 , , PUNCT dpc-1922 4 43 italy italy PROPN dpc-1922 4 44 2 2 NUM dpc-1922 4 45 dermatology dermatology NOUN dpc-1922 4 46 unit unit NOUN dpc-1922 4 47 , , PUNCT dpc-1922 4 48 department department NOUN dpc-1922 4 49 of of ADP dpc-1922 4 50 medicine medicine NOUN dpc-1922 4 51 , , PUNCT dpc-1922 4 52 university university PROPN dpc-1922 4 53 of of ADP dpc-1922 4 54 padova padova PROPN dpc-1922 4 55 , , PUNCT dpc-1922 4 56 italy italy PROPN dpc-1922 4 57 key key PROPN dpc-1922 4 58 words word NOUN dpc-1922 4 59 : : PUNCT dpc-1922 4 60 pd-1 pd-1 ADP dpc-1922 4 61 inhibitors inhibitor NOUN dpc-1922 4 62 , , PUNCT dpc-1922 4 63 dermatomyositis dermatomyositis NOUN dpc-1922 4 64 , , PUNCT dpc-1922 4 65 paraneoplastic paraneoplastic ADJ dpc-1922 4 66 , , PUNCT dpc-1922 4 67 breast breast NOUN dpc-1922 4 68 cancer cancer NOUN dpc-1922 4 69 , , PUNCT dpc-1922 4 70 immune immune NOUN dpc-1922 4 71 - - PUNCT dpc-1922 4 72 related relate VERB dpc-1922 4 73 adverse adverse ADJ dpc-1922 4 74 events event NOUN dpc-1922 4 75 citation citation NOUN dpc-1922 4 76 : : PUNCT dpc-1922 4 77 starace starace PROPN dpc-1922 4 78 m m PROPN dpc-1922 4 79 , , PUNCT dpc-1922 4 80 pampaloni pampaloni ADJ dpc-1922 4 81 f f X dpc-1922 4 82 , , PUNCT dpc-1922 4 83 carpanese carpanese PROPN dpc-1922 4 84 ma ma PROPN dpc-1922 4 85 , , PUNCT dpc-1922 4 86 et et PROPN dpc-1922 4 87 al al PROPN dpc-1922 4 88 . . PROPN dpc-1922 5 1 do do AUX dpc-1922 5 2 pd-1 pd-1 ADJ dpc-1922 5 3 / / SYM dpc-1922 5 4 pdl-1 pdl-1 NOUN dpc-1922 5 5 inhibitors inhibitor NOUN dpc-1922 5 6 play play VERB dpc-1922 5 7 a a DET dpc-1922 5 8 triggering trigger VERB dpc-1922 5 9 or or CCONJ dpc-1922 5 10 causative causative ADJ dpc-1922 5 11 role role NOUN dpc-1922 5 12 in in ADP dpc-1922 5 13 the the DET dpc-1922 5 14 development development NOUN dpc-1922 5 15 of of ADP dpc-1922 5 16 paraneoplastic paraneoplastic ADJ dpc-1922 5 17 dermatomyositis dermatomyositis NOUN dpc-1922 5 18 ? ? PUNCT dpc-1922 6 1 dermatol dermatol NOUN dpc-1922 6 2 pract pract PROPN dpc-1922 6 3 concept concept NOUN dpc-1922 6 4 . . PUNCT dpc-1922 7 1 2022;12(3):e2022105 2022;12(3):e2022105 X dpc-1922 7 2 . . X dpc-1922 7 3 doi doi PROPN dpc-1922 7 4 : : PUNCT dpc-1922 7 5 https://doi.org/10.5826/dpc.1203a105 https://doi.org/10.5826/dpc.1203a105 PROPN dpc-1922 7 6 accepted accept VERB dpc-1922 7 7 : : PUNCT dpc-1922 7 8 october october PROPN dpc-1922 7 9 25 25 NUM dpc-1922 7 10 , , PUNCT dpc-1922 7 11 2021 2021 NUM dpc-1922 7 12 ; ; PUNCT dpc-1922 7 13 published publish VERB dpc-1922 7 14 : : PUNCT dpc-1922 8 1 july july PROPN dpc-1922 8 2 2022 2022 NUM dpc-1922 8 3 copyright copyright NOUN dpc-1922 8 4 : : PUNCT dpc-1922 8 5 © © PROPN dpc-1922 8 6 2022 2022 NUM dpc-1922 8 7 starace starace NOUN dpc-1922 8 8 et et PROPN dpc-1922 8 9 al al PROPN dpc-1922 8 10 . . PUNCT dpc-1922 9 1 this this PRON dpc-1922 9 2 is be AUX dpc-1922 9 3 an an DET dpc-1922 9 4 open open ADJ dpc-1922 9 5 - - PUNCT dpc-1922 9 6 access access NOUN dpc-1922 9 7 article article NOUN dpc-1922 9 8 distributed distribute VERB dpc-1922 9 9 under under ADP dpc-1922 9 10 the the DET dpc-1922 9 11 terms term NOUN dpc-1922 9 12 of of ADP dpc-1922 9 13 the the DET dpc-1922 9 14 creative creative ADJ dpc-1922 9 15 commons common NOUN dpc-1922 9 16 attribution attribution NOUN dpc-1922 9 17 license license NOUN dpc-1922 9 18 ( ( PUNCT dpc-1922 9 19 by by ADP dpc-1922 9 20 - - PUNCT dpc-1922 9 21 nc-4.0 nc-4.0 NOUN dpc-1922 9 22 ) ) PUNCT dpc-1922 9 23 , , PUNCT dpc-1922 9 24 https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ PROPN dpc-1922 9 25 which which PRON dpc-1922 9 26 permits permit VERB dpc-1922 9 27 unrestricted unrestricted ADJ dpc-1922 9 28 noncommercial noncommercial ADJ dpc-1922 9 29 use use NOUN dpc-1922 9 30 , , PUNCT dpc-1922 9 31 distribution distribution NOUN dpc-1922 9 32 , , PUNCT dpc-1922 9 33 and and CCONJ dpc-1922 9 34 reproduction reproduction NOUN dpc-1922 9 35 in in ADP dpc-1922 9 36 any any DET dpc-1922 9 37 medium medium NOUN dpc-1922 9 38 , , PUNCT dpc-1922 9 39 provided provide VERB dpc-1922 9 40 the the DET dpc-1922 9 41 original original ADJ dpc-1922 9 42 authors author NOUN dpc-1922 9 43 and and CCONJ dpc-1922 9 44 source source NOUN dpc-1922 9 45 are be AUX dpc-1922 9 46 credited credit VERB dpc-1922 9 47 . . PUNCT dpc-1922 10 1 funding funding NOUN dpc-1922 10 2 : : PUNCT dpc-1922 10 3 none none NOUN dpc-1922 10 4 . . PUNCT dpc-1922 11 1 competing compete VERB dpc-1922 11 2 interests interest NOUN dpc-1922 11 3 : : PUNCT dpc-1922 11 4 none none NOUN dpc-1922 11 5 . . PUNCT dpc-1922 12 1 authorship authorship NOUN dpc-1922 12 2 : : PUNCT dpc-1922 12 3 all all DET dpc-1922 12 4 authors author NOUN dpc-1922 12 5 have have AUX dpc-1922 12 6 contributed contribute VERB dpc-1922 12 7 significantly significantly ADV dpc-1922 12 8 to to ADP dpc-1922 12 9 this this DET dpc-1922 12 10 publication publication NOUN dpc-1922 12 11 . . PUNCT dpc-1922 13 1 corresponding correspond VERB dpc-1922 13 2 author author NOUN dpc-1922 13 3 : : PUNCT dpc-1922 13 4 carpanese carpanese PROPN dpc-1922 13 5 miriam miriam PROPN dpc-1922 13 6 anna anna PROPN dpc-1922 13 7 , , PUNCT dpc-1922 13 8 md md PROPN dpc-1922 13 9 , , PUNCT dpc-1922 13 10 dermatology dermatology NOUN dpc-1922 13 11 -irccs -irccs PROPN dpc-1922 13 12 policlinico policlinico PROPN dpc-1922 13 13 di di PROPN dpc-1922 13 14 sant’orsola sant’orsola PROPN dpc-1922 13 15 department department PROPN dpc-1922 13 16 of of ADP dpc-1922 13 17 experimental experimental ADJ dpc-1922 13 18 , , PUNCT dpc-1922 13 19 diagnostic diagnostic ADJ dpc-1922 13 20 and and CCONJ dpc-1922 13 21 specialty specialty NOUN dpc-1922 13 22 medicine medicine NOUN dpc-1922 13 23 ( ( PUNCT dpc-1922 13 24 dimes dime NOUN dpc-1922 13 25 ) ) PUNCT dpc-1922 13 26 alma alma NOUN dpc-1922 13 27 mater mater NOUN dpc-1922 13 28 studiorum studiorum PROPN dpc-1922 13 29 university university PROPN dpc-1922 13 30 of of ADP dpc-1922 13 31 bologna bologna PROPN dpc-1922 13 32 , , PUNCT dpc-1922 13 33 via via ADP dpc-1922 13 34 massarenti massarenti PROPN dpc-1922 13 35 , , PUNCT dpc-1922 13 36 1 1 NUM dpc-1922 13 37 , , PUNCT dpc-1922 13 38 40138 40138 NUM dpc-1922 13 39 bologna bologna PROPN dpc-1922 13 40 , , PUNCT dpc-1922 13 41 italy italy PROPN dpc-1922 13 42 , , PUNCT dpc-1922 13 43 phone phone NOUN dpc-1922 13 44 : : PUNCT dpc-1922 13 45 +390512143677 +390512143677 DET dpc-1922 13 46 fax fax NOUN dpc-1922 13 47 : : PUNCT dpc-1922 13 48 +390512144867 +390512144867 NUM dpc-1922 13 49 e e NOUN dpc-1922 13 50 - - NOUN dpc-1922 13 51 mail mail NOUN dpc-1922 13 52 : : PUNCT dpc-1922 13 53 miriam.carpanese@gmail.com miriam.carpanese@gmail.com X dpc-1922 13 54 introduction introduction NOUN dpc-1922 13 55 the the DET dpc-1922 13 56 use use NOUN dpc-1922 13 57 of of ADP dpc-1922 13 58 immune immune ADJ dpc-1922 13 59 checkpoint checkpoint NOUN dpc-1922 13 60 inhibitors inhibitor NOUN dpc-1922 13 61 therapy therapy NOUN dpc-1922 13 62 in in ADP dpc-1922 13 63 cancers cancer NOUN dpc-1922 13 64 is be AUX dpc-1922 13 65 widely widely ADV dpc-1922 13 66 diffuse diffuse ADJ dpc-1922 13 67 but but CCONJ dpc-1922 13 68 the the DET dpc-1922 13 69 dermatologic dermatologic ADJ dpc-1922 13 70 immune immune NOUN dpc-1922 13 71 - - PUNCT dpc-1922 13 72 related relate VERB dpc-1922 13 73 adverse adverse ADJ dpc-1922 13 74 events event NOUN dpc-1922 13 75 ( ( PUNCT dpc-1922 13 76 iraes iraes NOUN dpc-1922 13 77 ) ) PUNCT dpc-1922 13 78 are be AUX dpc-1922 13 79 not not PART dpc-1922 13 80 completely completely ADV dpc-1922 13 81 characterized characterize VERB dpc-1922 13 82 . . PUNCT dpc-1922 14 1 we we PRON dpc-1922 14 2 present present VERB dpc-1922 14 3 the the DET dpc-1922 14 4 first first ADJ dpc-1922 14 5 case case NOUN dpc-1922 14 6 of of ADP dpc-1922 14 7 paraneoplastic paraneoplastic ADJ dpc-1922 14 8 dermatomyositis dermatomyositis NOUN dpc-1922 14 9 triggered trigger VERB dpc-1922 14 10 by by ADP dpc-1922 14 11 atezolizumab atezolizumab NOUN dpc-1922 14 12 . . PUNCT dpc-1922 15 1 case case NOUN dpc-1922 15 2 presentation presentation NOUN dpc-1922 15 3 a a DET dpc-1922 15 4 53 53 NUM dpc-1922 15 5 - - PUNCT dpc-1922 15 6 year year NOUN dpc-1922 15 7 - - PUNCT dpc-1922 15 8 old old ADJ dpc-1922 15 9 woman woman NOUN dpc-1922 15 10 affected affect VERB dpc-1922 15 11 by by ADP dpc-1922 15 12 ductal ductal PROPN dpc-1922 15 13 infiltrative infiltrative ADJ dpc-1922 15 14 breast breast NOUN dpc-1922 15 15 cancer cancer NOUN dpc-1922 15 16 underwent underwent NOUN dpc-1922 15 17 mastectomy mastectomy NOUN dpc-1922 15 18 and and CCONJ dpc-1922 15 19 lymphadenectomy lymphadenectomy NOUN dpc-1922 15 20 , , PUNCT dpc-1922 15 21 followed follow VERB dpc-1922 15 22 adjuvant adjuvant ADJ dpc-1922 15 23 chemotherapy chemotherapy NOUN dpc-1922 15 24 . . PUNCT dpc-1922 16 1 later later ADV dpc-1922 16 2 she she PRON dpc-1922 16 3 started start VERB dpc-1922 16 4 paclitaxel paclitaxel NOUN dpc-1922 16 5 weekly weekly ADV dpc-1922 16 6 and and CCONJ dpc-1922 16 7 atezolizumab atezolizumab NOUN dpc-1922 16 8 after after ADP dpc-1922 16 9 2 2 NUM dpc-1922 16 10 months month NOUN dpc-1922 16 11 . . PUNCT dpc-1922 17 1 at at ADP dpc-1922 17 2 the the DET dpc-1922 17 3 fifth fifth ADJ dpc-1922 17 4 infusion infusion NOUN dpc-1922 17 5 of of ADP dpc-1922 17 6 atezolizumab atezolizumab NOUN dpc-1922 17 7 she she PRON dpc-1922 17 8 developed develop VERB dpc-1922 17 9 a a DET dpc-1922 17 10 skin skin NOUN dpc-1922 17 11 rash rash NOUN dpc-1922 17 12 attributed attribute VERB dpc-1922 17 13 to to ADP dpc-1922 17 14 drug drug NOUN dpc-1922 17 15 . . PUNCT dpc-1922 18 1 dermatologic dermatologic ADJ dpc-1922 18 2 examination examination NOUN dpc-1922 18 3 revealed reveal VERB dpc-1922 18 4 marked mark VERB dpc-1922 18 5 butterfly butterfly NOUN dpc-1922 18 6 - - PUNCT dpc-1922 18 7 facial facial ADJ dpc-1922 18 8 edema edema NOUN dpc-1922 18 9 with with ADP dpc-1922 18 10 periocular periocular ADJ dpc-1922 18 11 swelling swelling NOUN dpc-1922 18 12 , , PUNCT dpc-1922 18 13 erythematous erythematous ADJ dpc-1922 18 14 - - PUNCT dpc-1922 18 15 violaceous violaceous ADJ dpc-1922 18 16 plaques plaque NOUN dpc-1922 18 17 of of ADP dpc-1922 18 18 the the DET dpc-1922 18 19 face face NOUN dpc-1922 18 20 , , PUNCT dpc-1922 18 21 upper upper ADJ dpc-1922 18 22 chest chest NOUN dpc-1922 18 23 and and CCONJ dpc-1922 18 24 back back ADV dpc-1922 18 25 . . PUNCT dpc-1922 19 1 ( ( PUNCT dpc-1922 19 2 figure figure NOUN dpc-1922 19 3 1a 1a NOUN dpc-1922 19 4 ) ) PUNCT dpc-1922 19 5 . . PUNCT dpc-1922 20 1 erythematous erythematous ADJ dpc-1922 20 2 papules papule NOUN dpc-1922 20 3 coalescing coalesce VERB dpc-1922 20 4 into into ADP dpc-1922 20 5 plaques plaque NOUN dpc-1922 20 6 of of ADP dpc-1922 20 7 the the DET dpc-1922 20 8 metacarpophalangeal metacarpophalangeal NOUN dpc-1922 20 9 and and CCONJ dpc-1922 20 10 proximal proximal ADJ dpc-1922 20 11 interphalangeal interphalangeal ADJ dpc-1922 20 12 joints joint NOUN dpc-1922 20 13 were be AUX dpc-1922 20 14 detected detect VERB dpc-1922 20 15 ( ( PUNCT dpc-1922 20 16 figure figure NOUN dpc-1922 20 17 1b 1b NUM dpc-1922 20 18 ) ) PUNCT dpc-1922 20 19 . . PUNCT dpc-1922 21 1 hemorrhagic hemorrhagic NOUN dpc-1922 21 2 onycholysis onycholysis NOUN dpc-1922 21 3 and and CCONJ dpc-1922 21 4 periungual periungual ADJ dpc-1922 21 5 erythema erythema NOUN dpc-1922 21 6 were be AUX dpc-1922 21 7 detected detect VERB dpc-1922 21 8 by by ADP dpc-1922 21 9 capillaroscopy capillaroscopy NOUN dpc-1922 21 10 that that PRON dpc-1922 21 11 revealed reveal VERB dpc-1922 21 12 capillary capillary ADJ dpc-1922 21 13 loss loss NOUN dpc-1922 21 14 , , PUNCT dpc-1922 21 15 tortuosity tortuosity NOUN dpc-1922 21 16 , , PUNCT dpc-1922 21 17 ramified ramify VERB dpc-1922 21 18 , , PUNCT dpc-1922 21 19 enlarged enlarged ADJ dpc-1922 21 20 capillaries capillary NOUN dpc-1922 21 21 , , PUNCT dpc-1922 21 22 and and CCONJ dpc-1922 21 23 microhemorrhages microhemorrhage NOUN dpc-1922 21 24 ( ( PUNCT dpc-1922 21 25 figure figure NOUN dpc-1922 21 26 1 1 NUM dpc-1922 21 27 , , PUNCT dpc-1922 21 28 c c NOUN dpc-1922 21 29 and and CCONJ dpc-1922 21 30 d d NOUN dpc-1922 21 31 ) ) PUNCT dpc-1922 21 32 . . PUNCT dpc-1922 22 1 a a DET dpc-1922 22 2     SPACE dpc-1922 22 3 skin skin NOUN dpc-1922 22 4 biopsy biopsy NOUN dpc-1922 22 5 from from ADP dpc-1922 22 6 a a DET dpc-1922 22 7 papule papule NOUN dpc-1922 22 8 of of ADP dpc-1922 22 9 the the DET dpc-1922 22 10 back back NOUN dpc-1922 22 11 of of ADP dpc-1922 22 12 the the DET dpc-1922 22 13 hand hand NOUN dpc-1922 22 14 showed show VERB dpc-1922 22 15 an an DET dpc-1922 22 16 interface interface NOUN dpc-1922 22 17 dermatitis dermatitis NOUN dpc-1922 22 18 and and CCONJ dpc-1922 22 19 focal focal ADJ dpc-1922 22 20 mucin mucin NOUN dpc-1922 22 21 deposition deposition NOUN dpc-1922 22 22 in in ADP dpc-1922 22 23 the the DET dpc-1922 22 24 dermis dermis NOUN dpc-1922 22 25 . . PUNCT dpc-1922 23 1 laboratory laboratory NOUN dpc-1922 23 2 testing testing NOUN dpc-1922 23 3 revealed reveal VERB dpc-1922 23 4 positive positive ADJ dpc-1922 23 5 ana ana PROPN dpc-1922 23 6 ( ( PUNCT dpc-1922 23 7 1:320 1:320 NOUN dpc-1922 23 8 ) ) PUNCT dpc-1922 23 9 , , PUNCT dpc-1922 23 10 normal normal ADJ dpc-1922 23 11 cpk cpk PROPN dpc-1922 23 12 ( ( PUNCT dpc-1922 23 13 212 212 NUM dpc-1922 23 14 u u NOUN dpc-1922 23 15 / / SYM dpc-1922 23 16 l l NOUN dpc-1922 23 17 ) ) PUNCT dpc-1922 23 18 , , PUNCT dpc-1922 23 19 mild mild ADJ dpc-1922 23 20 increased increase VERB dpc-1922 23 21 serum serum NOUN dpc-1922 23 22 aldolase aldolase NOUN dpc-1922 23 23 ( ( PUNCT dpc-1922 23 24 15.5 15.5 NUM dpc-1922 23 25 u u NOUN dpc-1922 23 26 / / SYM dpc-1922 23 27 l l NOUN dpc-1922 23 28 ) ) PUNCT dpc-1922 23 29 , , PUNCT dpc-1922 23 30 normal normal ADJ dpc-1922 23 31 transaminases transaminase NOUN dpc-1922 23 32 . . PUNCT dpc-1922 24 1 given give VERB dpc-1922 24 2 the the DET dpc-1922 24 3 clinical clinical ADJ dpc-1922 24 4 presentation presentation NOUN dpc-1922 24 5 , , PUNCT dpc-1922 24 6 capillaroscopy capillaroscopy NOUN dpc-1922 24 7 , , PUNCT dpc-1922 24 8 histopathology histopathology NOUN dpc-1922 24 9 and and CCONJ dpc-1922 24 10 ana ana PROPN dpc-1922 24 11 positivity positivity NOUN dpc-1922 24 12 2 2 NUM dpc-1922 24 13 research research NOUN dpc-1922 24 14 letter letter NOUN dpc-1922 24 15 | | ADV dpc-1922 24 16 dermatol dermatol ADJ dpc-1922 24 17 pract pract NOUN dpc-1922 24 18 concept concept NOUN dpc-1922 24 19 . . PUNCT dpc-1922 25 1 2022;12(3):e2022105 2022;12(3):e2022105 NUM dpc-1922 25 2 conclusions conclusion NOUN dpc-1922 25 3 pd-1 pd-1 ADJ dpc-1922 25 4 / / SYM dpc-1922 25 5 pdl-1 pdl-1 CCONJ dpc-1922 25 6 inhibitor inhibitor NOUN dpc-1922 25 7 immunotherapy immunotherapy NOUN dpc-1922 25 8 represents represent VERB dpc-1922 25 9 a a DET dpc-1922 25 10 successful successful ADJ dpc-1922 25 11 treatment treatment NOUN dpc-1922 25 12 for for ADP dpc-1922 25 13 advanced advanced ADJ dpc-1922 25 14 malignancies malignancy NOUN dpc-1922 25 15 ; ; PUNCT dpc-1922 25 16 it it PRON dpc-1922 25 17 can can AUX dpc-1922 25 18 be be AUX dpc-1922 25 19 associated associate VERB dpc-1922 25 20 with with ADP dpc-1922 25 21 lots lot NOUN dpc-1922 25 22 of of ADP dpc-1922 25 23 iraes irae NOUN dpc-1922 25 24 , , PUNCT dpc-1922 25 25 among among ADP dpc-1922 25 26 which which PRON dpc-1922 25 27 dermatomyositis dermatomyositis PROPN dpc-1922 25 28 . . PUNCT dpc-1922 26 1 guidelines guideline NOUN dpc-1922 26 2 recommend recommend VERB dpc-1922 26 3 temporary temporary ADJ dpc-1922 26 4 or or CCONJ dpc-1922 26 5 permanent permanent ADJ dpc-1922 26 6 drug drug NOUN dpc-1922 26 7 we we PRON dpc-1922 26 8 made make VERB dpc-1922 26 9 the the DET dpc-1922 26 10 diagnosis diagnosis NOUN dpc-1922 26 11 of of ADP dpc-1922 26 12 dermatomyositis dermatomyositis PROPN dpc-1922 26 13 . . PUNCT dpc-1922 27 1 between between ADP dpc-1922 27 2 myositis myositis NOUN dpc-1922 27 3 - - PUNCT dpc-1922 27 4 specific specific ADJ dpc-1922 27 5 antibodies antibody NOUN dpc-1922 27 6 requested request VERB dpc-1922 27 7 anti anti ADJ dpc-1922 27 8 - - ADJ dpc-1922 27 9 tif tif ADJ dpc-1922 27 10 ƴ ƴ PROPN dpc-1922 27 11 antibodies antibody NOUN dpc-1922 27 12 were be AUX dpc-1922 27 13 significantly significantly ADV dpc-1922 27 14 positive positive ADJ dpc-1922 27 15 ( ( PUNCT dpc-1922 27 16 negative negative ADJ dpc-1922 27 17 anti anti ADJ dpc-1922 27 18 - - ADJ dpc-1922 27 19 ro ro ADJ dpc-1922 27 20 and and CCONJ dpc-1922 27 21 anti anti ADJ dpc-1922 27 22 - - ADJ dpc-1922 27 23 jo jo ADJ dpc-1922 27 24 ) ) PUNCT dpc-1922 27 25 . . PUNCT dpc-1922 28 1 systemic systemic ADJ dpc-1922 28 2 prednisone prednisone NOUN dpc-1922 28 3 50 50 NUM dpc-1922 28 4 mg mg NOUN dpc-1922 28 5 daily daily ADV dpc-1922 28 6 and and CCONJ dpc-1922 28 7 intravenous intravenous ADJ dpc-1922 28 8 immunoglobulins immunoglobulin NOUN dpc-1922 28 9 were be AUX dpc-1922 28 10 prescribed prescribe VERB dpc-1922 28 11 with with ADP dpc-1922 28 12 improvement improvement NOUN dpc-1922 28 13 of of ADP dpc-1922 28 14 the the DET dpc-1922 28 15 clinical clinical ADJ dpc-1922 28 16 signs sign NOUN dpc-1922 28 17 ( ( PUNCT dpc-1922 28 18 figure figure NOUN dpc-1922 28 19 2 2 NUM dpc-1922 28 20 ) ) PUNCT dpc-1922 28 21 . . PUNCT dpc-1922 29 1 figure figure NOUN dpc-1922 29 2 1 1 NUM dpc-1922 29 3 . . PUNCT dpc-1922 30 1 ( ( PUNCT dpc-1922 30 2 a a X dpc-1922 30 3 ) ) PUNCT dpc-1922 30 4 facial facial ADJ dpc-1922 30 5 butterfly butterfly NOUN dpc-1922 30 6 - - PUNCT dpc-1922 30 7 edema edema NOUN dpc-1922 30 8 , , PUNCT dpc-1922 30 9 with with ADP dpc-1922 30 10 periocular periocular ADJ dpc-1922 30 11 swelling swelling NOUN dpc-1922 30 12 , , PUNCT dpc-1922 30 13 erythematous erythematous ADJ dpc-1922 30 14 - - PUNCT dpc-1922 30 15 to to ADP dpc-1922 30 16 - - PUNCT dpc-1922 30 17 slightly slightly ADV dpc-1922 30 18 - - PUNCT dpc-1922 30 19 violaceous violaceous NOUN dpc-1922 30 20 plaques plaque NOUN dpc-1922 30 21 sparing spare VERB dpc-1922 30 22 the the DET dpc-1922 30 23 frontal frontal ADJ dpc-1922 30 24 region region NOUN dpc-1922 30 25 and and CCONJ dpc-1922 30 26 the the DET dpc-1922 30 27 submental submental ADJ dpc-1922 30 28 area area NOUN dpc-1922 30 29 . . PUNCT dpc-1922 31 1 ( ( PUNCT dpc-1922 31 2 b b X dpc-1922 31 3 ) ) PUNCT dpc-1922 31 4 erythematous erythematous ADJ dpc-1922 31 5 discrete discrete ADJ dpc-1922 31 6 papules papule NOUN dpc-1922 31 7 coalescing coalesce VERB dpc-1922 31 8 into into ADP dpc-1922 31 9 plaques plaque NOUN dpc-1922 31 10 of of ADP dpc-1922 31 11 the the DET dpc-1922 31 12 metacarpophalangeal metacarpophalangeal NOUN dpc-1922 31 13 and and CCONJ dpc-1922 31 14 proximal proximal ADJ dpc-1922 31 15 interphalangeal interphalangeal ADJ dpc-1922 31 16 joints joint NOUN dpc-1922 31 17 . . PUNCT dpc-1922 32 1 ( ( PUNCT dpc-1922 32 2 c c X dpc-1922 32 3 ) ) PUNCT dpc-1922 32 4 capillaroscopic capillaroscopic ADJ dpc-1922 32 5 examination examination NOUN dpc-1922 32 6 : : PUNCT dpc-1922 32 7 capillary capillary ADJ dpc-1922 32 8 loss loss NOUN dpc-1922 32 9 , , PUNCT dpc-1922 32 10 tortuosity tortuosity NOUN dpc-1922 32 11 , , PUNCT dpc-1922 32 12 ramified ramify VERB dpc-1922 32 13 , , PUNCT dpc-1922 32 14 enlarged enlarged ADJ dpc-1922 32 15 and and CCONJ dpc-1922 32 16 giant giant ADJ dpc-1922 32 17 capillaries capillary NOUN dpc-1922 32 18 , , PUNCT dpc-1922 32 19 and and CCONJ dpc-1922 32 20 microhemorrhages microhemorrhage NOUN dpc-1922 32 21 50x 50x NUM dpc-1922 32 22 magnification magnification NOUN dpc-1922 32 23 . . PUNCT dpc-1922 33 1 ( ( PUNCT dpc-1922 33 2 d d X dpc-1922 33 3 ) ) PUNCT dpc-1922 33 4 70x 70x NOUN dpc-1922 33 5 magnification magnification NOUN dpc-1922 33 6 figure figure NOUN dpc-1922 33 7 2 2 NUM dpc-1922 33 8 . . PUNCT dpc-1922 34 1 the the DET dpc-1922 34 2 same same ADJ dpc-1922 34 3 patient patient NOUN dpc-1922 34 4 after after ADP dpc-1922 34 5 the the DET dpc-1922 34 6 therapy therapy NOUN dpc-1922 34 7 with with ADP dpc-1922 34 8 intravenous intravenous ADJ dpc-1922 34 9 immunoglobulin immunoglobulin NOUN dpc-1922 34 10 : : PUNCT dpc-1922 34 11 evident evident ADJ dpc-1922 34 12 improvement improvement NOUN dpc-1922 34 13 on on ADP dpc-1922 34 14 face face NOUN dpc-1922 34 15 ( ( PUNCT dpc-1922 34 16 a a NOUN dpc-1922 34 17 ) ) PUNCT dpc-1922 34 18 and and CCONJ dpc-1922 34 19 hands hand NOUN dpc-1922 34 20 ( ( PUNCT dpc-1922 34 21 b b NOUN dpc-1922 34 22 ) ) PUNCT dpc-1922 34 23 . . PUNCT dpc-1922 35 1 research research NOUN dpc-1922 35 2 letter letter NOUN dpc-1922 35 3 | | ADV dpc-1922 35 4 dermatol dermatol ADJ dpc-1922 35 5 pract pract NOUN dpc-1922 35 6 concept concept NOUN dpc-1922 35 7 . . PUNCT dpc-1922 36 1 2022;12(3):e2022105 2022;12(3):e2022105 NUM dpc-1922 36 2 3 3 NUM dpc-1922 36 3 this this DET dpc-1922 36 4 case case NOUN dpc-1922 36 5 adds add VERB dpc-1922 36 6 new new ADJ dpc-1922 36 7 findings finding NOUN dpc-1922 36 8 to to ADP dpc-1922 36 9 the the DET dpc-1922 36 10 literature literature NOUN dpc-1922 36 11 regarding regard VERB dpc-1922 36 12 dermatomyositis dermatomyositis PROPN dpc-1922 36 13 associated associate VERB dpc-1922 36 14 with with ADP dpc-1922 36 15 pd-1 pd-1 NOUN dpc-1922 36 16 / / SYM dpc-1922 36 17 pdl-1 pdl-1 ADJ dpc-1922 36 18 inhibitors inhibitor NOUN dpc-1922 36 19 . . PUNCT dpc-1922 37 1 pd-1 pd-1 ADJ dpc-1922 37 2 / / SYM dpc-1922 37 3 pdl-1 pdl-1 ADJ dpc-1922 37 4 inhibitors inhibitor NOUN dpc-1922 37 5 could could AUX dpc-1922 37 6 have have VERB dpc-1922 37 7 a a DET dpc-1922 37 8 triggering trigger VERB dpc-1922 37 9 role role NOUN dpc-1922 37 10 rather rather ADV dpc-1922 37 11 than than ADP dpc-1922 37 12 a a DET dpc-1922 37 13 causative causative ADJ dpc-1922 37 14 role role NOUN dpc-1922 37 15 in in ADP dpc-1922 37 16 the the DET dpc-1922 37 17 development development NOUN dpc-1922 37 18 of of ADP dpc-1922 37 19 dermatomyositis dermatomyositis PROPN dpc-1922 37 20 . . PUNCT dpc-1922 38 1 clinicians clinician NOUN dpc-1922 38 2 should should AUX dpc-1922 38 3 be be AUX dpc-1922 38 4 aware aware ADJ dpc-1922 38 5 that that SCONJ dpc-1922 38 6 facing face VERB dpc-1922 38 7 a a DET dpc-1922 38 8 patient patient NOUN dpc-1922 38 9 affected affect VERB dpc-1922 38 10 by by ADP dpc-1922 38 11 metastatic metastatic ADJ dpc-1922 38 12 cancer cancer NOUN dpc-1922 38 13 treated treat VERB dpc-1922 38 14 with with ADP dpc-1922 38 15 pd-1 pd-1 ADV dpc-1922 38 16 / / SYM dpc-1922 38 17 pdl-1 pdl-1 ADJ dpc-1922 38 18 inhibitors inhibitor NOUN dpc-1922 38 19 , , PUNCT dpc-1922 38 20 cutaneous cutaneous ADJ dpc-1922 38 21 adverse adverse ADJ dpc-1922 38 22 events event NOUN dpc-1922 38 23 such such ADJ dpc-1922 38 24 dermatomyositis dermatomyositis PROPN dpc-1922 38 25 may may AUX dpc-1922 38 26 be be AUX dpc-1922 38 27 not not PART dpc-1922 38 28 related relate VERB dpc-1922 38 29 to to ADP dpc-1922 38 30 the the DET dpc-1922 38 31 treatment treatment NOUN dpc-1922 38 32 but but CCONJ dpc-1922 38 33 also also ADV dpc-1922 38 34 to to ADP dpc-1922 38 35 the the DET dpc-1922 38 36 underlying underlie VERB dpc-1922 38 37 disease disease NOUN dpc-1922 38 38 , , PUNCT dpc-1922 38 39 preventing prevent VERB dpc-1922 38 40 the the DET dpc-1922 38 41 interruption interruption NOUN dpc-1922 38 42 of of ADP dpc-1922 38 43 safety safety NOUN dpc-1922 38 44 treatments treatment NOUN dpc-1922 38 45 . . PUNCT dpc-1922 39 1 references reference NOUN dpc-1922 39 2 1 1 NUM dpc-1922 39 3 . . PUNCT dpc-1922 40 1 messer messer PROPN dpc-1922 40 2 a a PROPN dpc-1922 40 3 , , PUNCT dpc-1922 40 4 drozd drozd PROPN dpc-1922 40 5 b b PROPN dpc-1922 40 6 , , PUNCT dpc-1922 40 7 glitza glitza PROPN dpc-1922 40 8 ic ic PROPN dpc-1922 40 9 , , PUNCT dpc-1922 40 10 lu lu PROPN dpc-1922 40 11 h h NOUN dpc-1922 40 12 , , PUNCT dpc-1922 40 13 patel patel PROPN dpc-1922 40 14 ab ab PROPN dpc-1922 40 15 . . PROPN dpc-1922 41 1 dermatomyositis dermatomyositis PROPN dpc-1922 41 2 associated associate VERB dpc-1922 41 3 with with ADP dpc-1922 41 4 nivolumab nivolumab NOUN dpc-1922 41 5 therapy therapy NOUN dpc-1922 41 6 for for ADP dpc-1922 41 7 melanoma melanoma NOUN dpc-1922 41 8 : : PUNCT dpc-1922 41 9 a a DET dpc-1922 41 10 case case NOUN dpc-1922 41 11 report report NOUN dpc-1922 41 12 and and CCONJ dpc-1922 41 13 review review NOUN dpc-1922 41 14 of of ADP dpc-1922 41 15 the the DET dpc-1922 41 16 literature literature NOUN dpc-1922 41 17 . . PUNCT dpc-1922 42 1 dermatol dermatol NOUN dpc-1922 42 2 online online ADV dpc-1922 42 3 j. j. PROPN dpc-1922 42 4 2020;26(8):13030 2020;26(8):13030 PROPN dpc-1922 42 5 / / SYM dpc-1922 42 6 qt4c21b068 qt4c21b068 NOUN dpc-1922 42 7 . . PUNCT dpc-1922 43 1 pmid pmid NOUN dpc-1922 43 2 : : PUNCT dpc-1922 43 3 32941716 32941716 NUM dpc-1922 43 4 . . X dpc-1922 44 1 2 2 X dpc-1922 44 2 . . X dpc-1922 44 3 didona didona PROPN dpc-1922 44 4 d d PROPN dpc-1922 44 5 , , PUNCT dpc-1922 44 6 fania fania PROPN dpc-1922 44 7 l l PROPN dpc-1922 44 8 , , PUNCT dpc-1922 44 9 didona didona PROPN dpc-1922 44 10 b b NOUN dpc-1922 44 11 , , PUNCT dpc-1922 44 12 eming eme VERB dpc-1922 44 13 r r NOUN dpc-1922 44 14 , , PUNCT dpc-1922 44 15 hertl hertl NOUN dpc-1922 44 16 m m PROPN dpc-1922 44 17 , , PUNCT dpc-1922 44 18 di di NOUN dpc-1922 44 19 zenzo zenzo NOUN dpc-1922 44 20 g. g. PROPN dpc-1922 44 21 paraneoplastic paraneoplastic PROPN dpc-1922 44 22 dermatoses dermatosis NOUN dpc-1922 44 23 : : PUNCT dpc-1922 44 24 a a DET dpc-1922 44 25 brief brief ADJ dpc-1922 44 26 general general ADJ dpc-1922 44 27 review review NOUN dpc-1922 44 28 and and CCONJ dpc-1922 44 29 an an DET dpc-1922 44 30 extensive extensive ADJ dpc-1922 44 31 analysis analysis NOUN dpc-1922 44 32 of of ADP dpc-1922 44 33 paraneoplastic paraneoplastic ADJ dpc-1922 44 34 pemphigus pemphigus NOUN dpc-1922 44 35 and and CCONJ dpc-1922 44 36 paraneoplastic paraneoplastic ADJ dpc-1922 44 37 dermatomyositis dermatomyositis PROPN dpc-1922 44 38 . . PUNCT dpc-1922 45 1 int int PROPN dpc-1922 45 2 j j PROPN dpc-1922 45 3 mol mol ADP dpc-1922 45 4 sci sci PROPN dpc-1922 45 5 . . PUNCT dpc-1922 46 1 2020;21(6):2178 2020;21(6):2178 NUM dpc-1922 46 2 . . PUNCT dpc-1922 47 1 doi doi NOUN dpc-1922 47 2 : : PUNCT dpc-1922 47 3 10.3390 10.3390 NUM dpc-1922 47 4 / / SYM dpc-1922 47 5 ijms21062178 ijms21062178 PROPN dpc-1922 47 6 . . PUNCT dpc-1922 48 1 pmid pmid NOUN dpc-1922 48 2 : : PUNCT dpc-1922 48 3 32245283 32245283 NUM dpc-1922 48 4 ; ; PUNCT dpc-1922 48 5 pmcid pmcid ADJ dpc-1922 48 6 : : PUNCT dpc-1922 48 7 pmc7139382 pmc7139382 ADJ dpc-1922 48 8 . . PUNCT dpc-1922 48 9 interruption interruption NOUN dpc-1922 48 10 according accord VERB dpc-1922 48 11 to to ADP dpc-1922 48 12 the the DET dpc-1922 48 13 severity severity NOUN dpc-1922 48 14 of of ADP dpc-1922 48 15 the the DET dpc-1922 48 16 skin skin NOUN dpc-1922 48 17 reaction reaction NOUN dpc-1922 48 18     SPACE dpc-1922 49 1 [ [ X dpc-1922 49 2 1 1 NUM dpc-1922 49 3 ] ] PUNCT dpc-1922 49 4 . . PUNCT dpc-1922 50 1 besides besides SCONJ dpc-1922 50 2 being be AUX dpc-1922 50 3 drug drug NOUN dpc-1922 50 4 - - PUNCT dpc-1922 50 5 induced induce VERB dpc-1922 50 6 , , PUNCT dpc-1922 50 7 dermatomyositis dermatomyositis PROPN dpc-1922 50 8 is be AUX dpc-1922 50 9 a a DET dpc-1922 50 10 well well ADV dpc-1922 50 11 described describe VERB dpc-1922 50 12 paraneoplastic paraneoplastic ADJ dpc-1922 50 13 disease disease NOUN dpc-1922 50 14 in in ADP dpc-1922 50 15 ovarian ovarian ADJ dpc-1922 50 16 and and CCONJ dpc-1922 50 17 breast breast NOUN dpc-1922 50 18 cancer cancer NOUN dpc-1922 50 19 . . PUNCT dpc-1922 51 1 the the DET dpc-1922 51 2 patient patient NOUN dpc-1922 51 3 described describe VERB dpc-1922 51 4 in in ADP dpc-1922 51 5 our our PRON dpc-1922 51 6 report report NOUN dpc-1922 51 7 had have VERB dpc-1922 51 8 the the DET dpc-1922 51 9 exposure exposure NOUN dpc-1922 51 10 to to PART dpc-1922 51 11 atezolizumab atezolizumab VERB dpc-1922 51 12 and and CCONJ dpc-1922 51 13 breast breast NOUN dpc-1922 51 14 cancer cancer NOUN dpc-1922 51 15 , , PUNCT dpc-1922 51 16 which which PRON dpc-1922 51 17 are be AUX dpc-1922 51 18 both both PRON dpc-1922 51 19 risk risk NOUN dpc-1922 51 20 factors factor NOUN dpc-1922 51 21 for for ADP dpc-1922 51 22 the the DET dpc-1922 51 23 development development NOUN dpc-1922 51 24 of of ADP dpc-1922 51 25 dermatomyositis dermatomyositis PROPN dpc-1922 51 26 . . PUNCT dpc-1922 52 1 at at ADP dpc-1922 52 2 the the DET dpc-1922 52 3 beginning beginning NOUN dpc-1922 52 4 we we PRON dpc-1922 52 5 believed believe VERB dpc-1922 52 6 that that SCONJ dpc-1922 52 7 dermatomyositis dermatomyositis PROPN dpc-1922 52 8 could could AUX dpc-1922 52 9 be be AUX dpc-1922 52 10 drug drug NOUN dpc-1922 52 11 induced induce VERB dpc-1922 52 12 , , PUNCT dpc-1922 52 13 due due ADP dpc-1922 52 14 to to ADP dpc-1922 52 15 the the DET dpc-1922 52 16 latency latency NOUN dpc-1922 52 17 between between ADP dpc-1922 52 18 the the DET dpc-1922 52 19 drug drug NOUN dpc-1922 52 20 infusion infusion NOUN dpc-1922 52 21 and and CCONJ dpc-1922 52 22 the the DET dpc-1922 52 23 onset onset NOUN dpc-1922 52 24 of of ADP dpc-1922 52 25 the the DET dpc-1922 52 26 reaction reaction NOUN dpc-1922 52 27 , , PUNCT dpc-1922 52 28 and and CCONJ dpc-1922 52 29 the the DET dpc-1922 52 30 strong strong ADJ dpc-1922 52 31 association association NOUN dpc-1922 52 32 between between ADP dpc-1922 52 33 antipd-1 antipd-1 PROPN dpc-1922 52 34 / / SYM dpc-1922 52 35 pdl-1 pdl-1 NOUN dpc-1922 52 36 therapy therapy NOUN dpc-1922 52 37 and and CCONJ dpc-1922 52 38 dermatomyositis dermatomyositis PROPN dpc-1922 52 39 . . PUNCT dpc-1922 53 1 nevertheless nevertheless ADV dpc-1922 53 2 , , PUNCT dpc-1922 53 3 the the DET dpc-1922 53 4 worsening worsen VERB dpc-1922 53 5 after after ADP dpc-1922 53 6 drug drug NOUN dpc-1922 53 7 discontinuation discontinuation NOUN dpc-1922 53 8 suggested suggest VERB dpc-1922 53 9 that that SCONJ dpc-1922 53 10 the the DET dpc-1922 53 11 antipd-1 antipd-1 NUM dpc-1922 53 12 / / SYM dpc-1922 53 13 pdl-1 pdl-1 PRON dpc-1922 53 14 was be AUX dpc-1922 53 15 only only ADV dpc-1922 53 16 a a DET dpc-1922 53 17 triggering trigger VERB dpc-1922 53 18 factor factor NOUN dpc-1922 53 19 for for ADP dpc-1922 53 20 a a DET dpc-1922 53 21 classical classical ADJ dpc-1922 53 22 paraneoplastic paraneoplastic ADJ dpc-1922 53 23 dermatomyositis dermatomyositis NOUN dpc-1922 53 24 . . PUNCT dpc-1922 54 1 paraneoplastic paraneoplastic ADJ dpc-1922 54 2 origin origin NOUN dpc-1922 54 3 was be AUX dpc-1922 54 4 supported support VERB dpc-1922 54 5 by by ADP dpc-1922 54 6 the the DET dpc-1922 54 7 presence presence NOUN dpc-1922 54 8 of of ADP dpc-1922 54 9 all all DET dpc-1922 54 10 the the DET dpc-1922 54 11 criteria criterion NOUN dpc-1922 54 12 proposed propose VERB dpc-1922 54 13 for for ADP dpc-1922 54 14 the the DET dpc-1922 54 15 diagnosis diagnosis NOUN dpc-1922 54 16 of of ADP dpc-1922 54 17 paraneoplastic paraneoplastic ADJ dpc-1922 54 18 dermatoses dermatosis NOUN dpc-1922 54 19 . . PUNCT dpc-1922 55 1 the the DET dpc-1922 55 2 disease disease NOUN dpc-1922 55 3 was be AUX dpc-1922 55 4 near near ADP dpc-1922 55 5 the the DET dpc-1922 55 6 beginning beginning NOUN dpc-1922 55 7 of of ADP dpc-1922 55 8 the the DET dpc-1922 55 9 cancer cancer NOUN dpc-1922 55 10 and and CCONJ dpc-1922 55 11 following follow VERB dpc-1922 55 12 the the DET dpc-1922 55 13 same same ADJ dpc-1922 55 14 course course NOUN dpc-1922 55 15 , , PUNCT dpc-1922 55 16 moreover moreover ADV dpc-1922 55 17 dermatomyositis dermatomyositis PROPN dpc-1922 55 18 is be AUX dpc-1922 55 19 rare rare ADJ dpc-1922 55 20 in in ADP dpc-1922 55 21 the the DET dpc-1922 55 22 general general ADJ dpc-1922 55 23 population population NOUN dpc-1922 55 24 but but CCONJ dpc-1922 55 25 strictly strictly ADV dpc-1922 55 26 associated associate VERB dpc-1922 55 27 to to ADP dpc-1922 55 28 tumors tumor NOUN dpc-1922 55 29 , , PUNCT dpc-1922 55 30 as as SCONJ dpc-1922 55 31 cancer cancer NOUN dpc-1922 55 32 occur occur VERB dpc-1922 55 33 in in ADP dpc-1922 55 34 14.8 14.8 NUM dpc-1922 55 35 % % NOUN dpc-1922 55 36 of of ADP dpc-1922 55 37 dermatomyositis dermatomyositis NOUN dpc-1922 55 38 patients patient NOUN dpc-1922 55 39 [ [ X dpc-1922 55 40 2 2 NUM dpc-1922 55 41 ] ] PUNCT dpc-1922 55 42 . . PUNCT dpc-1922 56 1 the the DET dpc-1922 56 2 detection detection NOUN dpc-1922 56 3 of of ADP dpc-1922 56 4 anti anti ADJ dpc-1922 56 5 - - ADJ dpc-1922 56 6 tif tif ADJ dpc-1922 56 7 ƴ ƴ NOUN dpc-1922 56 8 antibodies antibodie VERB dpc-1922 56 9 , , PUNCT dpc-1922 56 10 that that PRON dpc-1922 56 11 are be AUX dpc-1922 56 12 positive positive ADJ dpc-1922 56 13 in in ADP dpc-1922 56 14 42%-100 42%-100 NUM dpc-1922 56 15 % % NOUN dpc-1922 56 16 of of ADP dpc-1922 56 17 paraneoplastic paraneoplastic ADJ dpc-1922 56 18 dermatomyositis dermatomyositis NOUN dpc-1922 56 19 , , PUNCT dpc-1922 56 20 confirmed confirm VERB dpc-1922 56 21 our our PRON dpc-1922 56 22 diagnosis diagnosis NOUN dpc-1922 56 23 [ [ X dpc-1922 56 24 1 1 NUM dpc-1922 56 25 ] ] PUNCT dpc-1922 56 26 . . PUNCT